Improving patient outcomes in relapsing MS: Current oral DMTs and emerging therapies

2022-04-26

touchTALKS for touchNEUROLOGY Listen to a leading expert in multiple sclerosis (MS) discuss how disease-modifying therapies are currently used in clinical practice for the optimal management of relapsing MS. Prof. Patricia K Coyle highlights the importance of reducing the burden of the often ‘invisible’ symptoms of MS, such as fatigue, on overall patient quality of life, and reviews the latest, potentially practice-changing developments, which could further improve patient outcomes through shared treatment decision makin...

touchTALKS for touchNEUROLOGY

Listen to a leading expert in multiple sclerosis (MS) discuss how disease-modifying therapies are currently used in clinical practice for the optimal management of relapsing MS. Prof. Patricia K Coyle highlights the importance of reducing the burden of the often ‘invisible’ symptoms of MS, such as fatigue, on overall patient quality of life, and reviews the latest, potentially practice-changing developments, which could further improve patient outcomes through shared treatment decision making.

The expert

Prof. Patricia K Coyle, MS Comprehensive Care Center, Stony Brook University Hospital, Stony Brook, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Janssen Pharmaceutica NV. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurology.com/cme/dmts-in-rms/

Comments (3)